Integral Health Asset Management »

Alumis shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Alumis (ALMS) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Alumis

Tip: Access up to 7 years of quarterly data

All positions including Alumis held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alumis by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $18M 800k 22.03

More positions owned by Integral Health Asset Management

Revolution Medicines Put Option (RVMD)
Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Regeneron Pharmaceuticals (REGN)
Vera Therapeutics Cl A (VERA)
Cardinal Health (CAH)
Roivant Sciences SHS (ROIV)
Brightspring Health Svcs (BTSG)
Rhythm Pharmaceuticals (RYTM)
Merck & Co (MRK)
Edgewise Therapeutics (EWTX)
Astrazeneca Ord (AZN)
Alignment Healthcare (ALHC)
Novartis Sponsored Adr (NVS)
Boston Scientific Corporation (BSX)

View all positions for Integral Health Asset Management

Top funds holding Alumis

BlackRock
Deep Track Capital
Samsara BioCapital
Foresite Capital Management V
venBio Partners
Foresite Capital Management VI
Vanguard Capital Management
Cormorant Asset Management
Nextech Invest
Saturn V Capital Management
UBS Group
Octagon Capital Advisors
MPM Oncology Impact Management
Henderson Group
Baker Bros. Advisors

View all funds holding Alumis